Stay updated on Ixekizumab for Bullous Pemphigoid Clinical Trial
Sign up to get notified when there's something new on the Ixekizumab for Bullous Pemphigoid Clinical Trial page.

Latest updates to the Ixekizumab for Bullous Pemphigoid Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision identifiers updated to v3.3.4; previous v3.3.3 removed.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedA dedicated Locations section lists Arizona (Mayo Clinic, Scottsdale) for the study, replacing the old 'Arizona Locations' label. The HHS Vulnerability Disclosure link has been removed, and the page revision is now v3.3.3.SummaryDifference0.2%

- Check60 days agoChange DetectedRevision: v3.3.2 updates the page from v3.2.0. There are no substantive changes to study details or eligibility information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check67 days agoChange DetectedRemoved the banner about government funding status and potential delays. This notice was a site-wide banner, not part of the core trial information.SummaryDifference0.4%

- Check82 days agoChange DetectedThe study details page appears unchanged between the two screenshots. All sections and the overall layout remain the same.SummaryDifference0.5%

- Check110 days agoChange DetectedSummary: The page adds a government-operating-status notice and new version v3.2.0, replacing the old v3.1.0.SummaryDifference3%

Stay in the know with updates to Ixekizumab for Bullous Pemphigoid Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixekizumab for Bullous Pemphigoid Clinical Trial page.